Anemia increases the risk of renal cortical and medullary hypoxia during cardiopulmonary bypass
Anemia increases the risk of renal cortical and medullary hypoxia during cardiopulmonary bypass
复制标题
DOI:
10.1177/0267659113490219
复制
发表时间:
2013-11-01
期刊:
影响因子:
1.2
通讯作者:
Mazer, C. D.
中科院分区:
文献类型:
--
作者:
Darby, P. J.;Kim, N.;Mazer, C. D.
Introduction: Anemia is an independent predictor of acute kidney injury (AKI) following cardiopulmonary bypass (CPB), possibly due to inadequate renal oxygen delivery. The objective of this study was to investigate the effects of CPB and anemia on tissue oxygen tension (pO2) and blood flow in the renal cortex and medulla.Methods: Rats (n=6/group) underwent 1hr of normothermic cardiopulmonary bypass (CPB), with target hemoglobin concentrations (Hb) of 10g/dL (CPB) or 6.5g/dL (anemia-CPB). Renal blood flow (RBF) and tissue PO2 were measured before, during and after 1hr of CPB. To confirm the observed differences in renal cortical and medullary PO2, HIF-1 alpha (ODD) luciferase mice were exposed to 8% O-2 (hypoxia) and HIF-1 alpha dependent luminescence was measured in the renal cortex and medulla (n= 5).Results: Renal tissue PO2 values decreased initially and returned towards baseline, however, values at the end of CPB. Anemia-CPB resulted in a significant increase in both renal cortical and medullary blood flow, PO2 remained significantly reduced throughout anemia-CPB. Renal medullary HIF-1 alpha-dependent luminescence confirmed a greater degree of hypoxia in the renal medulla.Discussion: During CPB, renal O-2 delivery was transiently jeopardized, but recovered after 1hr. Anemia-CPB resulted in a dramatic and sustained reduction in renal cortical and medullary PO2, which suggests an increased risk of renal hypoxic injury with anemia.Conclusion: The clear difference in the degree of hypoxia in the renal cortex and medulla may be useful in understanding the progress of medullary hypoxia during CPB with anemia and the potential development of AKI. Further studies should aim at identifying early markers of medullary hypoxia and potential agents that may decrease the work and O-2 consumption in the renal medulla to reduce the risk of hypoxic damage during CPB and anemia.